SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-328886
Filing Date
2021-11-15
Accepted
2021-11-15 07:01:56
Documents
14
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d238968d8k.htm   iXBRL 8-K 25282
2 EX-99.1 d238968dex991.htm EX-99.1 95129
6 GRAPHIC g238968dsp.jpg GRAPHIC 2153
  Complete submission text file 0001193125-21-328886.txt   265266

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atai-20211115.xsd EX-101.SCH 2869
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20211115_lab.xml EX-101.LAB 18821
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20211115_pre.xml EX-101.PRE 11821
7 EXTRACTED XBRL INSTANCE DOCUMENT d238968d8k_htm.xml XML 3585
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 211406244
SIC: 2834 Pharmaceutical Preparations